Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
复制标题
高血糖和相关的高水平炎症与 2019 年冠状病毒病的严重程度呈正相关
DOI:
10.1155/2021/8812304
复制
发表时间:
2021
影响因子:
4.6
通讯作者:
Wang G
中科院分区:
文献类型:
--
作者:
Zhang W;Li C;Xu Y;He B;Hu M;Cao G;Li L;Wu S;Wang X;Zhang C;Zhao J;Xie J;Xu Z;Li Q;Wang G
Objective Coronavirus disease 2019 (COVID-19) is a considerable global public health threat. This study sought to investigate whether blood glucose (BG) levels or comorbid diabetes are associated with inflammatory status and disease severity in patients with COVID-19. Methods In this retrospective cohort study, the clinical and biochemical characteristics of COVID-19 patients with or without diabetes were compared. The relationship among severity of COVID-19, inflammatory status, and diabetes or hyperglycemia was analyzed. The severity of COVID-19 in all patients was determined according to the diagnostic and treatment guidelines issued by the Chinese National Health Committee (7th edition). Results Four hundred and sixty-one patients were enrolled in our study, and 71.58% of patients with diabetes and 13.03% of patients without diabetes had hyperglycemia. Compared with patients without diabetes (n = 366), patients with diabetes (n = 95) had a higher leucocyte count, neutrophil count, neutrophil to lymphocyte ratio (NLR), and erythrocyte sedimentation rate (ESR). There was no association between severity of COVID-19 and known diabetes adjusted for age, sex, body mass index (BMI), known hypertension, and coronary heart disease. The leucocyte count, NLR, and C-reactive protein (CRP) level increased with increasing BG level. Hyperglycemia was an independent predictor of critical (OR 4.00, 95% CI 1.72-9.30) or severe (OR 3.55, 95% CI 1.47-8.58) COVID-19, and of increased inflammatory levels (high leucocyte count (OR 4.26, 95% CI 1.65-10.97), NLR (OR 2.76, 95% CI 1.24-6.10), and CRP level (OR 2.49, 95% CI 1.19-5.23)), after adjustment for age, sex, BMI, severity of illness, and known diabetes. Conclusion Hyperglycemia was positively correlated with higher inflammation levels and more severe illness, and it is a risk factor for the increased severity of COVID-19. The initial measurement of plasma glucose levels after hospitalization may help identify a subset of patients who are predisposed to a worse clinical course.
登录
查看更多内容
影响因子:
5
作者:
Bode, Bruce;Garrett, Valerie;Klonoff, David C.
通讯作者:
Klonoff, David C.
影响因子:
168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者:
Cao, Bin
影响因子:
16.2
作者:
McAlister, FA;Majumdar, SR;Marrie, TJ
通讯作者:
Marrie, TJ
影响因子:
44.5
作者:
Forbes, Angus;Murrells, Trevor;Sinclair, Alan J.
通讯作者:
Sinclair, Alan J.
影响因子:
39
作者:
Wu, Chaomin;Chen, Xiaoyan;Song, Yuanlin
通讯作者:
Song, Yuanlin